AMGEN: TEZSPIRE 210 MG & 420 MG ACHIEVED 64.8% & 68.9% HISTOLOGIC REMISSION AT WEEK 24 VS 3.5% PLACEBO IN CROSSING TRIAL

Reuters · 5d ago

Please log in to view news